ADAPT as a single-domain bispecific scaffold capable of albumin-associated haf-life extension for therapeutic applications

Albumin-binding fusion partners are frequently used as a means for the in vivo half-life extension of small therapeutic molecules that would normally be cleared very rapidly from circulation. Howev ...